Headlands Technologies LLC Celldex Therapeutics, Inc. Transaction History

Headlands Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$32.76 - $42.56 $185,716 - $241,272	5,669 Added 161.37%	9,182 $339,000
Q1 2024 May 07, 2024	BUY	$35.22 - $51.88 $123,727 - $182,254	3,513 New	3,513 $147,000
Q3 2023 Nov 09, 2023	SELL	$25.45 - $37.46 $83,119 - $122,344	-3,266 Reduced 81.98%	718 $19,000
Q2 2023 Aug 03, 2023	BUY	$30.29 - $38.28 $120,675 - $152,507	3,984 New	3,984 $135,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.23B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.